Skip to main content

Shaka Devoxx

I'm back from the annual Devoxx conference, a fun and thoroughly exhausting week in Antwerp spent presenting, attending, and generally hanging out. It's always a great time, despite the weather and the overall grayscale cityscape.



This picture from the show was taken during one of my sessions when I was either talking about a GUI frame or saying hello to my Hawaiian friends.





I presented in several sessions, including 4 sessions with Romain Guy about Android and UI programming and one on topics from my book, Flex 4 Fun. I spent most of the week either on stage or writing slides and demos to present on stage. There's nothing like procrastination to keep you busy at the last minute.



For anyone that missed the presentations, see below about their availability on parleys.com. We may also post the slides someday, although it's always better to get the full deal (slides+audio+video). Also, I intend to post a couple of the demos I showed in the Android talks (the Flex demos are already available on the book site).



The sessions this year were, as always, recorded and will be released on parleys.com, an excellent site for viewing presentations with lots of content from previous years as well as other developer forums. The talks are released incrementally during the year for free, or you can buy a subscription to view them all for 79 Euros. In fact, parleys just announced that the 2009 recordings are now all available and all free. The talks and the recordings are of very high quality, so you should check out the site..



Anyway, thanks to Stephan Janssen for another great conference. Shaka!

Comments

Popular posts from this blog

Austerity-A Fancy Word for Destitute.

The reason for this post is not for the folks who have been caught in the first wave of personal economic hard reality, but the next wave. Regardless of the optimism espoused by grinning leaders and sycophant press, we are entering the final stage of global economic collapse. It began in 2008 and was forestalled for five years with fudge putty, but the weight of global indebtedness cannot be propped any longer and the final crunch is imminent. Austerity measures herald the final throes.  Indications of coming austerity.   Austerity measures are the final last ditch effort, futile or not! Back in the day many of us old-timers went through periods of "hard-times". In retrospect I realize there is no comparison to yesteryear hard times and today's version. Back then, expectations were never very high for the working class, there were no sophisticated systems or conveniences anyway. In fact the difference between being "set" or not was about having treats or not. Si...

Terrifying Arctic methane levels

A peak methane level of 3026 ppb was recorded by the MetOp-B satellite at 469 mb on December 11, 2021 am. This follows a peak methane level of  3644 ppb  recorded by the MetOp-B satellite at 367 mb on November 21, 2021, pm. A peak methane level of 2716 ppb was recorded by the MetOp-B satellite at 586 mb on December 11, 2021, pm, as above image shows. This image is possibly even more terrifying than the image at the top, as above image shows that at 586 mb, i.e. much closer to sea level, almost all methane shows up over sea, rather than over land, supporting the possibility of large methane eruptions from the seafloor, especially in the Arctic.  Also, the image was recorded later than the image at the top with the 3026 ppb peak, indicating that even more methane may be on the way. This appears to be confirmed by the Copernicus forecast for December 12, 2021, 03 UTC, as illustrated by the image below, which shows methane at 500 hPa (equivalent to 500 mb). Furthermore, ...

Women and children overboard

It's the  Catch-22  of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations,"  like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans."  Action began on that, too. There is still a long way to go. But this month there was a sign that ...